Entering text into the input field will update the search result below

Fortrea Holdings: Many Questions Post The Spin-Off

Aug. 20, 2023 6:37 AM ETFortrea Holdings Inc. (FTRE)LH5 Comments


  • Fortrea Holdings, a spin-off from LabCorp, has seen a substantial decline in its share price since its July spin-off.
  • The company has outlined a not-so-impressive outlook for the year, with flat earnings expected and a high leverage multiple.
  • Given this situation, it is hard to see appeal emerging here, as some execution is needed before I am considering a potential.
  • Looking for a helping hand in the market? Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate. Learn More »

Scientists working in the laboratory


Fortrea Holdings (NASDAQ:FTRE) was spun off from its former parent company LabCorp (LH) in July, as its shares have fallen quite a bit since that period of time. A $37 stock around the time of the spin-off has fallen to $26 here, as

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!

This article was written by

The Value Investor profile picture

The Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events.

As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capital allocation. Coverage includes 10 major events a month with an eye towards finding the best opportunities. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (5)

Spekulatius profile picture
I think you are better off just investing in CRL. better business, better balance sheet and similar valuation (based on EV/EBIT).
If FTRE can improve their margins, then this could become interesting.
It will be interesting to see if LH faces litigation over this spin. At the time of the spin they were referencing prior year EBITDA at 400mm…and then boom now it’s magically in the 200’s. I’ve already sold all my FTRE and LH.
Can't wait to sell my shares.
biochemist profile picture
FTRE is a dog. LH kept the revenue-generating central labs business and loaded up FTRE with debt.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About FTRE

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on FTRE

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.